Runnymede Capital Advisors, Inc. Novo Nordisk A S Transaction History
Runnymede Capital Advisors, Inc.
- $114 Billion
- Q4 2024
A detailed history of Runnymede Capital Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Runnymede Capital Advisors, Inc. holds 225 shares of NVO stock, worth $18,841. This represents 0.02% of its overall portfolio holdings.
Number of Shares
225Holding current value
$18,841% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,861Shares Held
327MCall Options Held
6.38MPut Options Held
7.57M-
Jennison Associates LLC19.9MShares$1.67 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.2 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.2 Billion0.14% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.09 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.06 Billion0.44% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $189B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...